Cryptococcus neoformans is an opportunistic fungus that causes life-threatening meningoencephalitis in 5-10% of patients with acquired immune deficiency syndrome. Cryptococcal meningoencephalitis is characterized by a lymphohistiocytic infiltrate, accumulation of encapsulated forms of C. neos6rmans, and varying degrees of glial reaction. Little is known about the contribution of endogenous central nervous system cells to the pathogenesis of cryptococcal infections. In this study, we investigated the role of astrocytes as potential effector cells against C. neoformans. Primary cultures of human fetal astrocytes, activated with interleukin 13 plus interferon 3' inhibited the growth of C. neoformans. The inhibition of C. neoformans growth was paralleled by production of nitrite, and reversed by the inhibitors of nitric oxide (NO-) synthase, NG-methyl-mono-arginine and NC-nitro-arginine methyl ester. The results suggest a novel function for human astrocytes in host defence and provide a precedent for the use of NO. as an antimicrobial effector molecule by human cells.
T
he fungus Cryptococcus neoformans is most often a pathogen for immunosuppressed individuals, and human infections almost always involve the brain (1, 2) . In the setting of AIDS, cryptococcal meningoencephalitis is difficult to treat because antifungal drugs seldom eradicate the infection (3). Cellmediated immunity is believed to be the major defence against C. neoformans (4) with antibody (5) and the complement system (6) providing important opsonins. Human neutrophils, lymphocytes (7, 8) , monocytes (9) , and alveolar macrophages (10) have each been reported to mediate antifungal activity in vitro. Some human effector cells, including NK cells, have been shown to require antibody for anticryptococcal activity (11) . In contrast to rodent macrophages which exert antifungal activities through nitric oxide (NO.)-mediated mechanisms (12) , the mechanisms by which human effector cells mediate antifungal activity are not well characterized.
The pathogenesis of central nervous system (CNS) infection by C. neoformans is poorly understood, but it is likely that local immunity is important in limiting the infection in the brain. Recent studies of mouse intracerebral injection models have suggested that CNS phagocytic mechanisms may be important in limiting cryptococcal infection (13) . Similarly, human microglial cells avidly phagocytose C. neoformans in the presence of specific antibody and mediate fungistasis independent of NO. production (Lee, S. C., and A. CasadevaU, unpublished observations). The purpose of this study was to examine the role of the astrocyte as a potential anticryptococcal effector cell. CNS tissue is characterized by an extensive neuroglial network; astrocytes are ubiquitous in the brain (14, 15) . In the subpial and perivascular zone, a specialized barrier formed by astrocytes (glia limitans) separates CNS parenchyma from subarachnoid space (14, 15 ) (see Fig. 1 ). The glia limitans is composed in part by basement membrane produced by astrocytes and permeable to diffusible molecules such as NO. or cytokines. Astrocytes are immunocompetent cells that can express immune molecules, present antigen, produce cytokines, and express activities of NO. synthase (NOS) (14, (16) (17) (18) (19) . Therefore we entertained the possibility that astrocytes could mediate antifungal activity by virtue of their capacity to produce soluble effector molecules, including NO..
Materials and Methods
Astrocyte Culture. Astrocyte cultures were prepared from second trimester human fetal abortuses, as previously described (19) . The purity of astrocytes was achieved by repeated trypsinization of mixed cultures and final cultures consisted of >99% glial fibrillary acidic protein-positive cells. Astrocytes seeded in 96-well, flat-bottom tissue culture plates at 104 cells per well in DMEM/10% heat-inactivated FCS were grown to reach confluence at 37~ in 5% CO2 (estimated final cell density was 20,000 cells per well).
Cell CFUAssay. Human fetal astrocytes were prepared and stimulated as described above, except that 24 h after the addition of fungi, the incubation was terminated and the number of viable fungi was determined by CFU assay. A companion set of cultures was prepared in which NC-methyl-mono-arginine (NMMA) or N~ - Fig. 4 shows a 24-h CFU assay done at the same E/T ratios as in Fig. 2 . There was a 52-64% inhibition of C. neoformans CFU in the presence of cytokine-activated astrocytes relative to nonactivated astrocytes. Measurement of nitrite production in parallel astrocyte cultures revealed nitrite levels of 10 _+ 1.0/~M in astrocyte cultures stimulated with cytokines compared with controls stimulated astrocytes were also treated with 200/~M of NMMA or NAME.
After 24 h of coculture with C. neoformans at various E/T ratios, cultures were terminated and CFUs were determined as described in Materials and Methods. Values shown are the mean and standard deviation of four replicate wells. Data represent one of two similar experiments. (*) Denote significant differences ~ <0.005) compared with controls (Student's t test).
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Lee et al. Brief Definitive Report that had nitrite levels of 1.6 + 1.0 #M (lower limit of sensitivity for assay). To demonstrate more directly the involvement of NO--mediated mechanisms in the antifungal effect, the 1.-arginine analogues, NMMA and NAME, were studied for their ability to inhibit the anticryptococcal activity of cytokine-stimulated astrocyte cultures. Fig. 4 shows that the addition of either inhibitor at a concentration of 200 #M completely inhibited the anticryptococcal activity of cytokineactivated astrocyte cultures. Nitrite levels measured in parallel wells demonstrated an 85 and 70% inhibition of nitrite production by NMMA and NAME, respectively, similar to the degree of inhibition reported by us (17) and others (21) at this concentration of inhibitors. Addition of IL-13 and IFN-3: alone or in combination without astrocytes, did not exert antifungal activity (data not shown).
Discussion
Two lines of evidence implicate NO. as the effector molecule in the astrocyte mediated inhibition of C. neoformans growth shown in this study: (a) nitrite, a byproduct of NO. synthase activity, was present only in cytokine-activated astrocytes cultures and its presence was associated with fungal growth inhibition; and (b) the I:arginine analogues NMMA and NAME completely abolished the antifungal effect of cytokine-activated astrocytes.
The magnitude of in vitro antifungal effects observed for cytokine-treated astrocytes is similar to that reported for other effector cells, such as macrophages (9), lymphocytes (7), and NK cells (11) . The E/T ratios at which astrocytes were shown to exert anticryptococcal activity were also comparable with E/T ratios at which peripheral immune cells have been shown to exhibit anticryptococcal activity (7, 9, 11) .
NO. and its derivatives have been shown to be important mediators of antifungal activity by murine macrophages (12, 22) and to directly inhibit C. neoformans in vitro (23) . In contrast to mice, human mononuclear phagocytes, including microglia, have no convincing inducible NOS activity (17, 21) , making it unlikely that NO. is an antimicrobial molecule used by human phagocytic cells. On the other hand, evidence presented here that activated astrocytes inhibit C. neoformans growth in part at least through NO.-mediated mechanism opens the possibility that similar antimicrobial mechanisms may be operant in vivo. A complex interactive network may exist among the various brain cell types to provide a coordinated local defense to infection. For example, microglia are eflicient phagocytic cells that produce IL-13 (18) , which is a potent inducer of nitrite synthesis by astrocytes (17) . IFN-% a T cell cytokine, in turn, provides an additional signal for nitrite production by astrocytes (17) .
In human infection, preliminary data suggest that the number of cryptococci in brain tissue is inversely correlated with the number of infiltrating inflammatory cells, including lymphocytes (Lee, S. C., unpublished observations). Cryptococcal meningoencephalitis in patients with AIDS often involves the accumulation of yeast in the brain with little inflammation or glial activation (2) . These cases may reflect a lack of proper signals for astrocyte activation.
The results of this study demonstrate that activated astrocytes can inhibit C. neoformans growth in vitro and strongly implicate NO. as an antifungal effector molecule in humans. The close proximity of astrocytes and C. neoformans cells in human cryptococcal meningoencephalitis suggests a novel role of activated astrocytes as antimicrobial effector cells. Therapeutic strategies directed at enhancing astrocyte activation may be useful in the therapy of human cryptococcosis.
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